Langerhans cell histiocytosis in adults: Report from the International Registry of the Histiocyte Society

European Journal of Cancer

Volumn 39, Issue 16, 2003, Pages 2341-2348

  Arico M ^a   Girschikofsky, M ^b   Genereau T ^c   Klersy, C ^d   McClain, K ^e   Grois, N ^f   Emile, J F ^g   Lukina, E ^h   De Juli, E ⁱ   Danesino, C ^j   Bernstrand, Cecilia ^l   Diez, Blanca ^l   Brezzi, Andrea ^k  

^a Ospedale dei Bambini G Di Cristina   (Italy)

^b ELISABETHINEN HOSPITAL   (Austria)

^c HÔPITAL SAINT ANTOINE   (France)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e TEXAS CHILDREN S HOSPITAL   (United States)

^f ST ANNA CHILDREN S HOSPITAL   (Austria)

^g HÔPITAL PAUL BROUSSE   (France)

^h NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

ⁱ OSPEDALE NIGUARDA CA GRANDA   (Italy)

^j UNIVERSITY OF PAVIA   (Italy)

^k UNIVERSITY OF MILAN   (Italy)

^l NONE

more..

Author keywords

Adults; Histiocyte society; International registry; Langerhans cell histiocytosis

Indexed keywords

ETOPOSIDE; STEROID; VINBLASTINE;

ADULT; ARTICLE; BIOPSY; BONE DISEASE; CIGARETTE SMOKING; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES INSIPIDUS; DIFFERENTIAL DIAGNOSIS; ENDOCRINE DISEASE; FAMILY HISTORY; FEMALE; FOLLOW UP; HEALTH CARE ORGANIZATION; HISTIOCYTOSIS X; HUMAN; LANGERHANS CELL; LANGERHANS CELL HISTIOCYTOSIS; LIVER DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; MUCOSA; PARENT; PATIENT INFORMATION; PRIORITY JOURNAL; REGISTER; SKIN DISEASE; STANDARD; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0141594802     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00672-5     Document Type: Article

References (35)

1. Nezelof C., Frileux Herbet F., Cronier Sachot J. Disseminated histiocytosis X: analysis of prognostic factors based on a retrospective study of 50 cases. Cancer. 44:1979;1824-1838.
2. Aricò M., Egeler R.M. Clinical aspects of Langerhans cell histiocytosis. Hematol./Oncol. Clin. North Am. 12:1998;247-258.
3. Lichtenstein L., Jaffe H.L. Eosinophilic granuloma of bone. Am. Pathol. 16:1940;595-604.
4. Lichtenstein L., Histiocytosis X. Integration of eosinophilic granuloma of bone, "Letter-Siwe disease" and "Schuller-Christian disease" as related manifestations of a single nosologic entity. AMA Arch. Pathol. 56:1953;84-102.
5. Abt A.F., Denholtz E.J. Letterer-Siwe's disease; splenomegaly associated with widespread hyperplasia of nonlipoid-storing macrophages; discussion of the so-called reticuloendotheliosis. Am. J. Dis. Child. 51:1936;499-522.
6. Letterer E. Aleukamische retikulose (ein Beitrag zden proliferativen Erkrankungen des Retikuloendothelialapparates). Frankf. Zeit. Pathol. 30:1924;377-394.
7. Siwe S. Die reticuloendotheliose - ein neues krankheitsbild unter den hepatosplenomegalien. Z. Kinderheilk. 55:1933;212-247.
8. Hand A. Polyuria and tuberculosis. Arch Pediatr. 10:1893;673-675.
9. Schuller A. Über eigenartige Schadeldefeckte im Jugendalter. Fortschr. Rontgenstr. 23:1915;12-18.
10. Christian H.A. Defect in membranous bones, exophtalmos and diabetes insipidus; an unusual syndrome of dyspituitarism. a clinical study Med. Clin. N. Am. 3:1919;849-861.
11. Chu T., D'Angio G.J., Favara B.E., Ladisch S., Nesbit M., Pritchard J. Histiocytosis syndromes in children [letter]. Lancet. 2:1987;41-42.
12. Favara B., Feller A., Paulli M.et al. Contemporary classification of histiocytic disorders. Med. Pediatr. Oncol. 29:1997;157-166.
13. Aricò M., Nichols K., Whitlock J.A.et al. Familial clustering of Langerhans cell histiocytosis. Br. J. Haematol. 107:1999;883-888.
14. Scappaticci M.A., Danesino C., Rossi E.et al. Cytogenetic abnormalities in PHA-stimulated lymphocytes from patients with Langerhans cell histiocytosis. Br. J. Haematol. 111:2000;258-262.
15. Aricò M., Danesino C. Langerhans' cell histiocytosis. is there a role for genetics? Haematologica. 86:2001;1009-1014.
16. Broadbent V., Gadner H., Komp D.M., Ladisch S. Histiocytosis syndromes in children. II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Clinical Writing Group of the Histiocyte Society Med. Pediatr. Oncol. 17:1989;492-495.
17. Gadner H., Grois N., Aricò M.et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J. Pediatr. 138:2001;728-734.
18. Kaltsas G.A., Powles T.B., Evanson J.et al. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis. clinical, endocrinological, and radiological features and response to treatment J. Clin. Endocrinol. Metab. 85:2000;1370-1376.
19. Howarth D.M., Gilchrist G.S., Mullan B.P., Wiseman G.A., Edmondson J.H., Schomberg P.J. Langerhans cell histiocytosis. diagnosis, natural history, management, and outcome Cancer. 85:1999;2278-2290.
20. Lahey E. Histiocytosis x - an analysis of prognostic factors. J. Pediatr. 87:1975;184-189.
21. Islinger R.B., Kuklo T.R., Owens B.D.et al. Langerhans' cell histiocytosis in patients older than 21 years. Clin. Orthop. 379:2000;231-235.
22. Maghnie M., Cosi G., Genovese E.et al. Central diabetes insipidus in children and adolescents. N. Engl. J. Med. 343:2000;998-1007.
23. Colby T.V., Lombard C. Histiocytosis X in the lung. Hum. Pathol. 14:1983;847-856.
24. Friedman P.J., Liebow A.A., Sokoloff J. Eosinophilic granuloma of lung. clinical aspects of primary histiocytosis in the adult Medicine (Baltimore). 60:1981;385-396.
25. Schonfeld N., Frank W., Wenig S.et al. Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration. 60:1993;38-44.
26. Zeid N.A., Muller H.K. Tobacco smoke induced lung granulomas and tumors. association with pulmonary Langerhans cells Pathology. 27:1995;247-254.
27. Vassallo R., Ryu J.H., Colby T.V., Hartman T., Limper A.H. Pulmonary Langerhans' - cell histiocytosis. N. Engl. J. Med. 342:2000;1969-1978.
28. Willis B., Ablin A., Weinberg V., Zoger S., Wara W.M., Matthay K.K. Disease course and late sequelae of Langerhans' cell histiocytosis. 25-year experience at the University of California, San Francisco J. Clin. Oncol. 14:1996;2073-2082.
29. Braier J., Chantada G., Rosso D.et al. Langerhans cell histiocytosis. retrospective evaluation of 123 patients at a single institution Pediatr. Hematol. Oncol. 16:1999;377-385.
30. A multicentre retrospective survey of Langerhans' cell histiocytosis. 348 cases observed between 1983 and 1993 Arch. Dis. Child. 75:1996;17-24.
31. Callebaut W., Demedts M., Verleden G. Pulmonary Langerhans' cell granulomatosis (histiocytosis X). clinical analysis of 8 cases Acta Clin. Belg. 53:1998;337-343.
32. Habib S.B., Congleton J., Carr D.et al. Recurrence of recipient Langerhans' cell histiocytosis following bilateral lung transplantation. Thorax. 53:1998;323-325.
33. Etienne B., Bertocchi M., Gamondes J.P.et al. Relapsing pulmonary Langerhans cell histiocytosis after lung transplantation. Am. J. Respir. Crit. Care Med. 157:1998;288-291.
34. Harari S., Simonneau G., De Juli E.et al. Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation. J. Heart Lung Transplant. 16:1997;460-463.
35. Loire R., Brune J. Severe late stage lesions of pulmonary histiocytosis X. Report of 3 transplantations. Rev. Mal. Respir. 10:1993;223-228.